S&T Bank’s Novo Nordisk NVO Stock Holding History

S&T Bank’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62.3K	Sell	1,300 -130	-9%	-$5.58K	0.02%	158
2026 Q1	$52.6K	Hold	1,430	–	–	0.02%	162
2025 Q4	$72.8K	Hold	1,430	–	–	0.02%	147
2025 Q3	$79.4K	Hold	1,430	–	–	0.02%	147
2025 Q2	$98.7K	Hold	1,430	–	–	0.03%	130
2025 Q1	$99.3K	Hold	1,430	–	–	0.03%	125
2024 Q4	$123K	Buy	+1,430	New	+$155K	0.04%	113
2024 Q3	–	Sell	-1,430	Closed	-$204K	–	102
2024 Q2	$204K	Sell	1,430 -200	-12%	-$26.5K	0.05%	96
2024 Q1	$209K	Buy	+1,630	New	+$194K	0.04%	97
2023 Q1	–	Sell	-6,570	Closed	-$445K	–	109
2022 Q4	$445K	Sell	6,570 -600	-8%	-$35.2K	0.08%	80
2022 Q3	$357K	Sell	7,170 -4,700	-40%	-$252K	0.07%	87
2022 Q2	$661K	Hold	11,870	–	–	0.12%	88
2022 Q1	$659K	Hold	11,870	–	–	0.1%	93
2021 Q4	$665K	Hold	11,870	–	–	0.1%	96
2021 Q3	$570K	Sell	11,870 -42	-0.4%	-$2.03K	0.09%	99
2021 Q2	$499K	Sell	11,912 -4	-0%	-$155	0.08%	103
2021 Q1	$402K	Buy	11,916 +16	+0.1%	+$570	0.07%	104
2020 Q4	$416K	Buy	+11,900	New	+$411K	0.07%	102

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

S&T Bank's NVO Position: Q2 2026 in Review

S&T Bank reduced its Novo Nordisk (NVO) stake by 9.1% in Q2 2026, selling an estimated $5.58K and leaving 1,300 shares worth $62.3K. The position accounts for 0.02% of the portfolio, ranked #158.

S&T Bank first reported a position in NVO in Q4 2020 and has held it in 18 quarters since. The position peaked at $665K in Q4 2021. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

S&T Bank held 1,300 shares of Novo Nordisk worth $62.3K as of Q2 2026.
S&T Bank sold 130 Novo Nordisk shares in Q2 2026, an estimated $5.58K.
Novo Nordisk made up 0.02% of S&T Bank's portfolio in Q2 2026, its #158 holding.
S&T Bank first reported a position in Novo Nordisk in Q4 2020 and has held it in 18 quarters since.
S&T Bank's Novo Nordisk position peaked at $665K in Q4 2021.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on S&T Bank's 13F filing for Q2 2026, filed 12 Aug 2026.